Kabeer Aziz - Jun 6, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director, 10%+ Owner
Signature
/s/ Kabeer Aziz
Stock symbol
ANTX
Transactions as of
Jun 6, 2022
Transactions value $
$0
Form type
4
Date filed
6/24/2022, 05:10 PM
Previous filing
May 16, 2022
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Other -$398K -26.5K -1.2% $15.00 2.18M Jun 6, 2022 By Adjuvant Global Health Technology Fund, L.P. F1, F2
transaction ANTX Common Stock Other $398K +26.5K +6.86% $15.00 413K Jun 6, 2022 By Adjuvant Global Health Technology Fund DE, L.P. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 6, 2022, Adjuvant Global Health Technology Fund, L.P. ("AGHT Fund") transferred to Adjuvant Global Health Technology Fund DE, L.P. ("AGHT Fund DE") 26,511 shares of the Issuer's common stock, with a value of $15.00 per share, which is the per share cost of the shares acquired by AGHT Fund.
F2 Shares held directly by AGHT Fund. The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. ("AC GP") and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. ("AC MGMT"). The Reporting Person is a member of the Issuer's board of directors and is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.
F3 Shares held directly by AGHT Fund DE. The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is AC MGMT. The Reporting Person is a member of the Issuer's board of directors and is Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.